Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Stomach Neoplasms 6Neoplasms 2Lymphoma, Non-Hodgkin 2Helicobacter Infections 2Gastroesophageal Reflux 2Breast Neoplasms 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Erosive Reflux Disease 1Neoplasm Metastasis 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hemorrhage 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis, Atrophic 1Fatigue 1Familial primary gastric lymphoma 1Esophageal Neoplasms 1Delayed Bleeding 1

Interventions

Rituximab 161Cyclophosphamide 142fludarabine phosphate 89Peripheral Blood Stem Cell Transplantation 81Filgrastim 59Mycophenolic Acid 58Whole-Body Irradiation 53Cyclosporine 53Radiotherapy 52Lenalidomide 47Busulfan 45Tacrolimus 44Etoposide 43Antilymphocyte Serum 41Melphalan 37Methotrexate 31fludarabine 30Bortezomib 30Prednisone 28Bendamustine Hydrochloride 28Cytarabine 24Cord Blood Stem Cell Transplantation 23obinutuzumab 22Vincristine 22Methylprednisolone 21Flow Cytometry 21ibrutinib 19venetoclax 18sargramostim 17Granulocyte Colony-Stimulating Factor 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell, Marginal Zone × Proton Pump Inhibitors × Clear all
NCT00154440 2007-03-26

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Technische Universität Dresden

Phase 3 Unknown
200 enrolled
GastrointestinalLymphoid

Familial primary gastric lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡